Grzegorz M. Popowicz

Schlumberger (British Virgin Islands) — VG

Medicine · Health Sciences

40h-index7.8kcitations187works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(19), Peptidase Inhibition and Analysis(18), Ubiquitin and proteasome pathways(16), Computational Drug Discovery Methods(15), Trypanosoma species research and implications(15)

Publications185 total

The essential co-chaperone Sgt1 regulates client dwell time in the Hsp90 chaperone cycle
Molecular Cell·2025Open Access
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis
Cell·2025· 5 citedOpen Access
Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity
Virology·2025Open Access
The <i>Paulinella</i> chromatophore transit peptide part2 adopts a structural fold similar to the γ-glutamyl-cyclotransferase fold
PLANT PHYSIOLOGY·2025Open Access
It’s Not Always Crystal Clear: In-Pocket Analysis for Understanding Binding Site Microenvironment Properties
2025Open Access
A universal model for drug-receptor interactions
2025Open Access
Quantum mechanics-driven structure-activity relationship study of PEX5-PEX14 protein-protein interaction inhibitors based on a dibenzo[b,e]azepin-6(6H)-one scaffold
European Journal of Medicinal Chemistry·2025· 1 citedOpen Access
Moderne Medikamentenentwicklung
Uro-News·2025
Enhancing Catalytic Activity of a Baeyer–Villiger monooxygenase from <i>Oceanicola granulosus</i>: Simultaneous Engineering of the Distal Site and Active Site
Journal of Agricultural and Food Chemistry·2025· 2 cited
Uncovering the Unexpected Role of Proteasome Activator PA200 in Regulating Immunoproteasome Expression and Activity
2025Open Access
The essential co-chaperone Sgt1 regulates client dwell time in the Hsp90 chaperone cycle
2025Open Access
Revealing the unexpected interplay between the Proteasome Activator PA200 and the immunoproteasome
2025Open Access
Quantum Mechanics-Driven Structure-Activity Relationship Study of Pex5-Pex14 Protein-Protein Interaction Inhibitors Based on a Dibenzo[B,E]Azepin-6(6h)-One Scaffold
SSRN Electronic Journal·2025Open Access
The Paulinella chromatophore transit peptide part2 adopts a structural fold similar to the γ-glutamyl-cyclotransferase fold
DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron)·2025Open Access
Structural dynamics of the TPR domain of the peroxisomal cargo receptor Pex5 in Trypanosoma
International Journal of Biological Macromolecules·2024· 4 citedOpen Access
Acriflavine as an inhibitor of PlPro SARS-CoV-2: repurposing an old drug for a novel challenge
Acta Crystallographica Section A Foundations and Advances·2024
Corrigendum to “SARS-CoV-2 Mpro oligomerization as a potential target for therapy” [Int. J. Biol. Macromol. 267 (Part 1) (May 2024) 131392]
International Journal of Biological Macromolecules·2024Open Access
Curcumin Inhibition of DYRK Kinases
2024Open Access
MISATO: machine learning dataset of protein–ligand complexes for structure-based drug discovery
Nature Computational Science·2024· 51 citedOpen Access
Moderne Medikamentenentwicklung durch den Einbezug künstlicher Intelligenz
InFo Hämatologie + Onkologie·2024
page 1 of 10Next →

Frequent Co-authors

Tad A. Holak(29), Michael Sattler(14), Anna Czarna(10), Grzegorz Dubin(9), Alexander Dömlingꝉ(8), Robert Huber(7), Siglinde Wolf(7), Michał Biśta(5), Jan Potempa(5), Marcin Krajewski(4), Kareem Khoury(4), Justyna Stec-Niemczyk(4), Adam Dubin(4), André Mourão(3), Michael Schleicher(3), Angelika A. Noegel(3), Yijun Huang(3), Kenji Schorpp(3), Kamyar Hadian(3), Oliver Plettenburg(3)